We did not specify why the WHO may or may not approve our vaccine to the Canadian government.
First, the fact that PMI was a minority shareholder was already public information. Second, the WHO used a kind of exceptional treatment in the pandemic situation. We discussed with the WHO to prepare for our application, but when they reviewed it, the situation changed.